Humanigen, Inc.: Humanigen Launches Managed Access Program f

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' announced today that lenzilumab is now

Related Keywords

United States , United Kingdom , Luxembourg , Portugal , Austria , Estonia , Netherlands , Denmark , Croatia , Italy , Sweden , Bulgaria , Ireland , Lithuania , France , Spain , Cyprus , Switzerland , Greece , America , Rob Fox , Timothye Morris , Asia Pacific , Pete Belden , Andrea Aroldi , Twitter , Services Division , Nasdaq , Access Program Lenz , Corporate Development , Clinigen Group , European Union , Humanigen Inc , Facebook , Consilium Strategic Communications , Managed Access Program , Executive Vice President Services Division , San Gerardo Hospital , Host Disease , North America , Investor Relations , Strategic Communications , Jane Elliott Matthew Cole Jessica Hodgson , Humanigen , Aunches , Anaged , Access , Program , Lenzilumab ,